FDA Inspection 779430 — Hetero Drugs Limited

Hetero Drugs Limited — FEI 3009225386

The FDA completed an inspection of Hetero Drugs Limited on Dec 15, 2011 in Anakapalli. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Dec 15, 2011
Fiscal Year
2012
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Anakapalli (India)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.